Escherichia Coli Bacteria

Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.

A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi. The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...

Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.

A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi. The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...